Global cancer statistics, CA Cancer J Clin, vol.55, issue.2, pp.74-108, 2002. ,
Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care, Am Soc Clin Oncol Educ Book, pp.296-303, 2014. ,
Assessing and improving quality of life in patients with head and neck cancer, Am Soc Clin Oncol Educ Book, 2013. ,
Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results, Head Neck, vol.38, issue.1, pp.1481-1487, 2016. ,
Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy, Int J Radiat Oncol Biol Phys, vol.7, issue.5, pp.621-630, 1981. ,
Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: a study of 19 human tumour cell lines from different origin, Radiother Oncol, vol.73, issue.3, pp.373-82, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00388960
Proteomic profiling identifies PTK2/ FAK as a driver of radioresistance in HPV negative head and neck cancer, Clin Cancer Res, vol.22, issue.18, pp.4643-50, 2016. ,
Investigation of radiosensitivity gene signatures in cancer cell lines, PLoS One, vol.9, issue.1, p.86329, 2014. ,
Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma, Cancer Biol Ther, vol.10, issue.12, pp.1244-51, 2010. ,
Gene expression profiling to predict outcome after chemoradiation in head and neck cancer, Int J Radiat Oncol Biol Phys, vol.69, issue.5, pp.1544-52, 2007. ,
Purity for clarity: the need for purification of tumor cells in DNA microarray studies, Leukemia, vol.19, issue.4, pp.618-645, 2005. ,
Inferring tumour purity and stromal and immune cell admixture from expression data, Nat Commun, vol.4, p.2612, 2013. ,
Systematic pan-cancer analysis of tumour purity, Nat Commun, vol.6, p.8971, 2015. ,
Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma, Cancer, vol.92, issue.4, pp.805-818, 2001. ,
Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives, Cancer Treat Rev, vol.41, issue.10, pp.844-52, 2015. ,
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, J Natl Cancer Inst, vol.100, issue.4, pp.261-270, 2008. ,
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials, Eur J Cancer, vol.50, issue.15, pp.2636-2684, 2014. ,
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives, Int J Cancer, vol.136, issue.7, pp.1494-503, 2015. ,
CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis, Int J Cancer, vol.132, issue.2, pp.26-36, 2013. ,
Role of cell cycle in mediating sensitivity to radiotherapy, Int J Radiat Oncol Biol Phys, vol.59, issue.4, pp.928-970, 2004. ,
EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines, J Oral Pathol Med, vol.42, issue.1, pp.26-36, 2013. ,
Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications, Head Neck, vol.37, issue.5, pp.763-70, 2015. ,
Pretreatment microRNA expression impacting on epithelial-to-mesenchymal transition predicts intrinsic radiosensitivity in head and neck cancer cell lines and patients, Clin Cancer Res, vol.21, issue.24, pp.5630-5638, 2015. ,
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression, Cancer Cell, vol.5, issue.5, pp.489-500, 2004. ,
Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes, PLoS One, vol.8, issue.2, p.56823, 2013. ,
Cell Miner: a relational database and query tool for the NCI-60 cancer cell lines, BMC Genomics, vol.10, p.277, 2009. ,
Cell Miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set, Cancer Res, vol.72, issue.14, pp.3499-511, 2012. ,
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen, Cancer Res, vol.68, issue.2, pp.415-439, 2008. ,
Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells, BMC Genomics, vol.13, p.348, 2012. ,
A landscape of pharmacogenomic interactions in cancer, Cell, vol.166, issue.3, pp.740-54, 2016. ,
Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells, Nucleic Acids Res, vol.41, pp.955-961, 2013. ,
TCGA2STAT: simple TCGA data access for integrated statistical analysis in R, Bioinformatics, vol.32, issue.6, pp.952-956, 2016. ,
Broad Institute TCGA Genome Data Analysis Center: SNP6 Copy number analysis (GISTIC2), Broad Institute of MIT and Harvard, Mutation Analysis (MutSig v2.0), 2016. ,
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers, Genome Biol, vol.12, issue.4, p.41, 2011. ,
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, issue.5, pp.401-405, 2012. ,
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, vol.6, issue.269, p.1, 2013. ,
TCPA: a resource for cancer functional proteomics data, Nat Methods, vol.10, issue.11, pp.1046-1053, 2013. ,
Selection and validation of differentially expressed genes in head and neck cancer, Cell Mol Life Sci, vol.61, issue.11, pp.1372-83, 2004. ,
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer, Int J Cancer, vol.137, issue.12, pp.2846-57, 2015. ,
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, vol.462, issue.7269, pp.108-120, 2009. ,
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci, vol.102, issue.43, pp.15545-50, 2005. ,
The Molecular Signatures Database (MSigDB) hallmark gene set collection, Cell Syst, vol.1, issue.6, pp.417-442, 2015. ,
Open source software for the analysis of microarray data, Biotechniques, pp.45-51, 2003. ,
GenePattern 2.0, Nat Genet, vol.38, issue.5, pp.500-501, 2006. ,
Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha, Mol Cell Biol, vol.22, issue.24, pp.8506-8519, 2002. ,
Targeting HSP90 and monoclonal protein trafficking modulates the unfolded protein response, chaperone regulation and apoptosis in myeloma cells, Blood Cancer J, vol.3, p.167, 2013. ,
Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand, Radiother Oncol, vol.119, issue.1, pp.145-154, 2016. ,
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation, Int J Radiat Oncol Biol Phys, vol.75, issue.2, pp.489-96, 2009. ,
Targeting the unfolded protein response in disease, Nat Rev Drug Discov, vol.12, issue.9, pp.703-722, 2013. ,